Extended Lipid Test: What It Measures and Why It Matters

Quick facts

• A standard lipid profile is the starting point for most cholesterol and cardiovascular risk assessments.
• An extended lipid profile can add markers such as apolipoprotein B (ApoB) and lipoprotein(a), or Lp(a).
• ApoB reflects the concentration of potentially atherogenic lipoprotein particles, while Lp(a) is largely genetically determined.
• More measurements do not automatically mean better clinical decisions: some advanced markers have a less established role in routine care.
• Blood results should be interpreted alongside blood pressure, smoking status, diabetes, family history and overall cardiovascular risk.

What is an Extended Lipid test?

An extended lipid test, sometimes called an advanced cholesterol test or extended lipid profile, measures more than the traditional cholesterol markers.

It can be useful when a clinician wants to understand inherited lipid-related risk, investigate a mismatch between cholesterol results and other risk factors, or assess aspects of lipoprotein metabolism that standard testing does not show.

It is not a replacement for a standard cholesterol test or a cardiovascular risk assessment.

For many people, a routine lipid profile provides the information needed to start a conversation about prevention and treatment. The value of additional biomarkers depends on the question being asked.

Standard cholesterol test vs extended lipid profile

A routine lipid profile typically includes total cholesterol, HDL cholesterol and triglycerides, alongside calculated LDL cholesterol and non-HDL cholesterol.

An extended profile builds on this foundation with selected additional measurements.

What do the standard cholesterol markers mean?

LDL cholesterol (LDL-C)

LDL particles carry cholesterol through the bloodstream. Higher cumulative exposure to LDL cholesterol contributes to atherosclerosis, the gradual build-up of plaque within artery walls.

LDL-C remains a central marker for assessing and treating lipid-related cardiovascular risk.

HDL cholesterol (HDL-C)

HDL particles are involved in cholesterol transport and recycling. HDL-C is often called “good cholesterol”, but a high HDL-C result does not guarantee protection from heart disease.

It should not be assessed in isolation.

Triglycerides and non-HDL cholesterol

Triglycerides are fats used and stored for energy. Higher levels can accompany insulin resistance, diabetes and other metabolic conditions. Non-HDL cholesterol is total cholesterol minus HDL-C; it captures the cholesterol carried in several potentially atherogenic lipoprotein groups and is useful in UK cardiovascular care.

Which additional biomarkers can an extended lipid test measure?

The extended lipid panel described here includes Lp(a), apolipoproteins A-I, B, C-II, C-III and E, the ApoB/A-I ratio and small LDL cholesterol. Each provides a different perspective, but their clinical relevance is not identical.

Exact analyte availability should always be confirmed against the current laboratory test specification.

Lipoprotein(a): a largely inherited risk factor

Lipoprotein(a), written Lp(a), is an LDL-like particle with an additional protein, apolipoprotein(a), attached. Lp(a) concentration is largely inherited.

An individual can have an otherwise unremarkable cholesterol profile yet have elevated Lp(a).

Higher Lp(a) is associated with an increased lifetime risk of atherosclerotic cardiovascular disease and calcific aortic valve stenosis. This matters particularly when there is a family history of premature heart disease, stroke or familial hypercholesterolaemia.

The 2025 European Society of Cardiology/European Atherosclerosis Society update advises considering Lp(a) measurement at least once in adult life. Measuring it does not diagnose heart disease, but a high result can prompt a more informed discussion about managing other modifiable risk factors.

Apolipoprotein B (ApoB): cholesterol cargo vs particle number

LDL-C measures how much cholesterol is carried within LDL particles. ApoB helps estimate the number of circulating atherogenic lipoprotein particles, because each of these particles carries one ApoB molecule.

These measurements usually follow similar patterns, but not always. For example, someone with insulin resistance or elevated triglycerides may have relatively modest LDL-C despite a higher concentration of ApoB-containing particles.

This is sometimes called LDL-C/ApoB discordance.

Want to understand this distinction in more detail? Read ApoB vs LDL Cholesterol: What’s the Difference?

Apolipoprotein A-I and the ApoB/A-I ratio

Apolipoprotein A-I (ApoA-I) is a major structural protein within HDL particles. The ApoB/A-I ratio compares the concentration of ApoB with ApoA-I.

It can provide additional information about lipoprotein balance, although it is not a substitute for established risk assessment or standard lipid targets.

Apolipoproteins C-II, C-III and E

ApoC-II helps activate lipoprotein lipase, an enzyme involved in triglyceride breakdown. ApoC-III influences the processing and clearance of triglyceride-rich particles. ApoE plays a role in the recognition and clearance of lipoprotein remnants.

These proteins are interesting aspects of lipid metabolism, but routine measurements of ApoC-II, ApoC-III and ApoE have less clearly established roles in everyday cardiovascular risk assessment than LDL-C, non-HDL-C, ApoB and Lp(a). Importantly, measuring ApoE protein in blood is not the same as an APOE genetic test and does not establish APOE4 carrier status.

Small LDL cholesterol: what does it add?

Small LDL cholesterol reflects cholesterol within a subset of smaller, denser LDL particles.

These patterns can be associated with higher triglycerides and insulin resistance, but the added clinical value of measuring LDL particle size or subfractions routinely remains uncertain.

A small LDL result should therefore be interpreted cautiously rather than used alone to diagnose cardiovascular disease or guide treatment. Established lipid markers and the wider clinical picture remain more important.

Who might benefit from an extended cholesterol test?

Additional testing may be worth discussing with a qualified healthcare professional if you:

• Have a family history of premature cardiovascular disease, stroke or familial hypercholesterolaemia.

• Have raised cholesterol or triglycerides, or metabolic risk factors such as diabetes or insulin resistance.

• Have a standard cholesterol result that appears inconsistent with your wider health or family history.

• Are already managing cardiovascular risk and want to understand whether additional measurements would change your care.

• Have never had Lp(a) measured and would like to discuss whether a once-in-adulthood test is appropriate.

An extended test is not automatically necessary for everyone. Whether to order additional markers should depend on the clinical context and whether the result is likely to inform a decision.

How should extended lipid results be interpreted?

Cholesterol and lipoprotein results are one part of risk assessment, not a diagnosis by themselves.

UK guidance recommends considering cardiovascular risk using clinical information such as age, blood pressure, smoking, diabetes, kidney function, family history and existing disease.

For eligible adults without established cardiovascular disease, clinicians may use QRISK3 to support an estimate of 10-year risk.

Context matters. Thyroid disease, poorly controlled diabetes, kidney disorders, some medicines and other health factors can alter lipid concentrations. Results may need to be compared with previous measurements or repeated when clinically indicated.

An elevated result does not prove you have a blocked artery. Likewise, a result inside a laboratory reference interval cannot exclude cardiovascular disease.

Do you need to fast for an extended lipid test?

Not always. NICE guidance does not require fasting for a routine lipid profile, and non-fasting blood tests are appropriate for many people. There are exceptions, particularly when triglycerides are markedly elevated or when other tests within a combined panel require specific preparation, like our Prestige Health test that includes nutrient status and other markers where fasting is required.

Follow the preparation instructions provided for your exact My Atlas panel rather than assuming every cholesterol test requires fasting.

If you take medication, do not stop it unless advised by your prescribing clinician.

What can you do if your cholesterol or ApoB is high?

Depending on your overall risk and results, a clinician may recommend dietary changes, regular physical activity, smoking cessation, managing blood pressure or diabetes, and lipid-lowering medication. Statins and other treatments have established roles for appropriately selected patients.

Lp(a) is different: lifestyle measures usually have little effect on the Lp(a) level itself, but managing LDL-C, blood pressure and other risks remains valuable.

Your next step should be based on your complete risk profile, not one number.

Extended lipid testing: seeing the wider picture

An extended lipid test can help answer questions a standard cholesterol measurement does not always resolve. Lp(a) may highlight an inherited influence on risk; ApoB can add context about the burden of atherogenic particles; and other apolipoproteins can provide supplementary biochemical information.

The aim is not to collect as many numbers as possible. It is to choose meaningful markers, interpret them together and use the findings to support informed decisions about long-term cardiovascular health.

Explore testing with My Atlas: Extended Lipids (Cholesterol) Blood Test

For broader cardiovascular assessment: Cardiovascular Health Blood Test

Frequently Asked Questions (FAQs)

Is an extended lipid test better than a standard cholesterol test?

Not necessarily. A standard lipid profile is sufficient for many routine assessments. An extended test may add useful information in selected situations, particularly through ApoB and Lp(a).

Can my cholesterol be normal but my cardiovascular risk still be high?

Yes. Cholesterol is only one risk factor. Family history, smoking, blood pressure, diabetes and inherited factors such as elevated Lp(a) can matter even when routine results appear reassuring.

Does a high ApoB mean I have heart disease?

No. Higher ApoB can indicate a greater concentration of potentially atherogenic particles, but it does not diagnose plaque or coronary artery disease.

Is ApoE testing the same as an APOE4 genetic test?

No.

A measurement of apolipoprotein E protein is different from testing the APOE gene. An ApoE protein blood result cannot tell you whether you carry APOE4.

How often should I repeat an extended lipid panel?

The interval depends on the reason for testing, treatment and previous results. Lp(a) usually needs measuring only once in adulthood, whereas LDL-C and non-HDL-C may be repeated to monitor lipid-lowering treatment.

Ask your clinician which markers genuinely need repeating.